https://www.selleckchem.com/products/GDC-0449.html
17, 95% CI 0.30-4.52, P = 0.82). Conclusion We report no significant differences between CoHXLPE and CoC in adults undergoing primary THA. Although introduced relatively recently, CoHXLPE is a cost-effective bearing that can be used for younger patients with no risk of increased complications in comparison to CoC. Further studies with longer follow-up periods are recommended to confirm the findings of this meta-analysis. The presence of band cells 10% of the total white blood cell (WBC) count ("bandemia" is often used as an indic
Like
Comment
Share
